CIGARETTE-SMOKE INHIBITS LUNG FIBROBLAST PROLIFERATION AND CHEMOTAXIS

被引:131
作者
NAKAMURA, Y
ROMBERGER, DJ
TATE, L
ERTL, RF
KAWAMOTO, M
ADACHI, Y
MIO, T
SISSON, JH
SPURZEM, JR
RENNARD, SI
机构
[1] UNIV NEBRASKA, MED CTR, DEPT INTERNAL MED, PULM & CRIT CARE MED SECT, OMAHA, NE 68198 USA
[2] UNIV TOKUSHIMA, SCH MED, DEPT INTERNAL MED 3, TOKUSHIMA 770, JAPAN
[3] NIPPON MED COLL, DEPT PATHOL 1, TOKYO, JAPAN
关键词
D O I
10.1164/ajrccm.151.5.7735606
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Cigarette smoking is the most clearly recognized cause of pulmonary emphysema. Since loss of lung tissue, which characterizes emphysema, represents a balance between injury and repair, we hypothesized that cigarette smoke might contribute to the development of emphysema by inhibiting fibroblast proliferation and migration. To evaluate this, we examined the effect of cigarette smoke extract (CSE) on the proliferation and migration of human lung fibroblasts in vitro. CSE inhibited fibroblast proliferation and migration at noncytotoxic concentrations. When CSE was treated to remove volatile components, it showed less inhibitory activity on fibroblast proliferation. Therefore, we also examined acrolein and acetaldehyde, which are volatile components of cigarette smoke. Micromolar concentrations of acrolein and millimolar concentrations of acetaldehyde induced significant inhibition of fibroblast proliferation. In contrast, removal of volatile components did not eliminate the inhibitory activity of CSE for fibroblast migration, although acetaldehyde and acrolein alone were also capable of inhibiting chemotaxis. Cigarette smoke-induced inhibition of fibroblast proliferation and migration may impair lung repair following lung injury, and may thus contribute to the development of pulmonary emphysema.
引用
收藏
页码:1497 / 1503
页数:7
相关论文
共 29 条
[1]  
Higgins M.W., Keller J.B., Becker M., Howatt W., Landis J.R., Rotman H., Weg J.G., Higgins I., An index of risk for obstructive airways disease, Am. Rev. Respir. Dis., 116, pp. 403-410, (1982)
[2]  
Higgins M., Epidemiology of COPD: State of the art, Chest, 85, (1986)
[3]  
The Health Consequences of Smoking. A Report of the Surgeon General, (1984)
[4]  
Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service, pp. 14-57
[5]  
Buist A.S., Smoking and other risk factors, Textbook of Respiratory Therapy, pp. 1001-1029, (1988)
[6]  
Ogushi F., Hubbard R.C., Vogelmeier C., Fells G.A., Crystal R.G., Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha-1 antitrypsin for neutrophil elastase, J. Clin. Invest., 87, pp. 1060-1065, (1991)
[7]  
Auerbach O., Hammond E.C., Garfinkel L., Benante C., Relation of smoking and age to emphysema. Whole-lung section study, N. Engl. J. Med., 286, pp. 853-857, (1972)
[8]  
Thurlbeck W.M., Henderson J.A., Fraser R.G., Bates D.V., Chronic obstructive lung disease. A comparison between clinical, roentgenologic, functional and morphologic criteria in chronic bronchitis, emphysema, asthma, and bronchiectasis, Medicine, 49, pp. 81-145, (1970)
[9]  
Janoff A., Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis, Am. Rev. Respir. Dis., 132, pp. 417-433, (1985)
[10]  
Snider G.L., Kleinerman J., Thurlbeck W.M., Bengali Z.H., The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop, Am. Rev. Respir. Dis., 132, pp. 182-185, (1985)